Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
1 "These early data suggest that a well-tolerated, 1-time procedure like Revita could offer patients a new, sustainable path forward without the need for ongoing medical treatment." In the REVEAL-1 trial, 15 patients were treated
Your response to the treatment will determine if you will continue taking the injection after this period
Some individuals prioritize convenience, while others focus on maximizing results
developmental code PNB-0408) is a synthetic small oligopeptide derived from angiotensin IV (AngIV), engineered to overcome AngIVs limitations as a research tool by adding lipophilic modifications that confer oral bioavailability and blood-brain barrier permeability
Whenever possible, patients should self-monitor blood glucose concentrations
Step 1: inspect the vial Hold it up to a bright light
US$ 27.40
US$ 24.90
US$ 28.38
US$ 21.12
US$ 22.64
US$ 20.90
US$ 24.18
